Differential case ascertainment in clinical registry versus administrative data and impact on outcomes assessment for pediatric cardiac operations.

PubWeight™: 2.22‹?› | Rank: Top 2%

🔗 View Article (PMC 3777807)

Published in Ann Thorac Surg on November 07, 2012

Authors

Sara K Pasquali1, Eric D Peterson, Jeffrey P Jacobs, Xia He, Jennifer S Li, Marshall L Jacobs, J William Gaynor, Jennifer C Hirsch, Samir S Shah, John E Mayer

Author Affiliations

1: Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA. pasquali@med.umich

Articles citing this

Pediatric and neonatal extracorporeal membrane oxygenation: does center volume impact mortality?*. Crit Care Med (2014) 4.12

Quality-Cost Relationship in Congenital Heart Surgery. Ann Thorac Surg (2015) 1.45

Variation in congenital heart surgery costs across hospitals. Pediatrics (2014) 1.22

Excess costs associated with complications and prolonged length of stay after congenital heart surgery. Ann Thorac Surg (2014) 1.03

Increased trauma center volume is associated with improved survival after severe injury: results of a Resuscitation Outcomes Consortium study. Ann Surg (2014) 0.97

Measuring hospital performance in congenital heart surgery: administrative versus clinical registry data. Ann Thorac Surg (2015) 0.94

Hospital variation in postoperative infection and outcome after congenital heart surgery. Ann Thorac Surg (2013) 0.90

The Impact of Differential Case Ascertainment in Clinical Registry Versus Administrative Data on Assessment of Resource Utilization in Pediatric Heart Surgery. World J Pediatr Congenit Heart Surg (2014) 0.89

Accuracy of the all patient refined diagnosis related groups classification system in congenital heart surgery. Ann Thorac Surg (2013) 0.86

Population-based study of hospital costs for hospitalizations of infants, children, and adults with a congenital heart defect, Arkansas 2006 to 2011. Birth Defects Res A Clin Mol Teratol (2015) 0.86

Morbidity and mortality in patients with esophageal atresia. Surgery (2014) 0.83

Congenital heart operations performed in the first year of life: does geographic variation exist? Ann Thorac Surg (2014) 0.79

Development and Validation of an Agency for Healthcare Research and Quality Indicator for Mortality After Congenital Heart Surgery Harmonized With Risk Adjustment for Congenital Heart Surgery (RACHS-1) Methodology. J Am Heart Assoc (2016) 0.77

Outcomes associated with the use of renal replacement therapy in children receiving extracorporeal membrane oxygenation after heart surgery: a multi-institutional analysis. Pediatr Nephrol (2014) 0.76

Linking clinical research data to population databases. Nurs Res (2013) 0.75

Completeness and Accuracy of Local Clinical Registry Data for Children Undergoing Heart Surgery. Ann Thorac Surg (2016) 0.75

Variability in noncardiac surgical procedures in children with congenital heart disease. J Pediatr Surg (2014) 0.75

Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group. Pediatr Blood Cancer (2015) 0.75

Costs, mortality, and hospital usage in relation to prenatal diagnosis in d-transposition of the great arteries. Birth Defects Res (2017) 0.75

Invited commentary. Ann Thorac Surg (2012) 0.75

Impact of Timing of ECMO Initiation on Outcomes After Pediatric Heart Surgery: A Multi-Institutional Analysis. Pediatr Cardiol (2016) 0.75

Articles cited by this

Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg (2002) 6.92

Variation in outcomes for benchmark operations: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. Ann Thorac Surg (2011) 2.67

Comparison of clinical and administrative data sources for hospital coronary artery bypass graft surgery report cards. Circulation (2007) 2.55

Nomenclature for congenital and paediatric cardiac disease: historical perspectives and The International Pediatric and Congenital Cardiac Code. Cardiol Young (2008) 2.10

The importance of nomenclature for congenital cardiac disease: implications for research and evaluation. Cardiol Young (2008) 1.92

Linking clinical registry data with administrative data using indirect identifiers: implementation and validation in the congenital heart surgery population. Am Heart J (2010) 1.87

Perioperative methylprednisolone and outcome in neonates undergoing heart surgery. Pediatrics (2012) 1.75

Validity of hospital discharge data for identifying infants with cardiac defects. J Perinatol (2005) 1.74

Databases for assessing the outcomes of the treatment of patients with congenital and paediatric cardiac disease--the perspective of cardiac surgery. Cardiol Young (2008) 1.63

Comparison of pediatric cardiac surgical mortality rates from national administrative data to contemporary clinical standards. Ann Thorac Surg (2009) 1.50

Completeness of state administrative databases for surveillance of congenital heart disease. Birth Defects Res A Clin Mol Teratol (2003) 1.36

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. J Thorac Cardiovasc Surg (2012) 1.23

Articles by these authors

Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol (2007) 10.19

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70

Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38

Application of new cholesterol guidelines to a population-based sample. N Engl J Med (2014) 8.22

Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med (2013) 8.08

Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA (2009) 7.78

ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol (2006) 7.77

Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation (2007) 6.78

2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2009) 6.61

Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med (2007) 6.22

Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA (2005) 5.93

Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49

Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med (2010) 5.43

Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med (2009) 5.19

Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA (2013) 5.05

Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA (2007) 4.89

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2009) 4.75

The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis (2011) 4.71

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation (2011) 4.65

2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57

Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 4.44

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 4.39

Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation (2007) 4.36

Compliance with results reporting at ClinicalTrials.gov. N Engl J Med (2015) 4.17

Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA (2010) 4.13

Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2006) 4.11

An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg (2009) 4.10

Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA (2008) 4.06

Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg (2002) 3.86

Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med (2005) 3.83

Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA (2007) 3.79

Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Ann Intern Med (2002) 3.77

Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med (2010) 3.72

Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA (2005) 3.72

Conversion of cardiovascular conference abstracts to publications. Circulation (2012) 3.71

Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA (2011) 3.68

Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA (2012) 3.66

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60

Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J (2009) 3.57

Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol (2009) 3.54

Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation (2006) 3.45

Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA (2004) 3.45

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg (2009) 3.45

Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA (2011) 3.44

Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation. Circulation (2005) 3.38

Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation (2006) 3.38

2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol (2011) 3.37

Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation (2011) 3.30

Association between physician billing and cardiac stress testing patterns following coronary revascularization. JAMA (2011) 3.19

Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis (2011) 3.16

Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA (2012) 3.07

Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation (2012) 3.02

Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery. JAMA (2012) 3.00

Use of aldosterone antagonists in heart failure. JAMA (2009) 3.00

Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Mol Genet Metab (2010) 2.99

Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA (2008) 2.96

Laparoscopic versus open appendectomy: outcomes comparison based on a large administrative database. Ann Surg (2004) 2.95

Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation (2009) 2.93

Peer-reviewed publication of clinical trials completed for pediatric exclusivity. JAMA (2006) 2.92

A decade of change--risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg (2002) 2.91

2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2012) 2.88

Outcomes following transcatheter aortic valve replacement in the United States. JAMA (2013) 2.88

The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg (2003) 2.86

Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol (2010) 2.86

Verification of data in congenital cardiac surgery. Cardiol Young (2008) 2.84

An MRI study of neurological injury before and after congenital heart surgery. Circulation (2002) 2.83

Identifying frailty in hospitalized older adults with significant coronary artery disease. J Am Geriatr Soc (2006) 2.82

Use of both internal thoracic arteries in diabetic patients increases deep sternal wound infection. Ann Thorac Surg (2007) 2.82

A taxonomy for disease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group. Circulation (2006) 2.81

Early postoperative outcomes in a series of infants with hypoplastic left heart syndrome undergoing stage I palliation operation with either modified Blalock-Taussig shunt or right ventricle to pulmonary artery conduit. Pediatr Crit Care Med (2006) 2.77

Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation (2007) 2.76

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2011) 2.72

Brain maturation is delayed in infants with complex congenital heart defects. J Thorac Cardiovasc Surg (2009) 2.71

The value of statistical analysis plans in observational research: defining high-quality research from the start. JAMA (2012) 2.69

Racial differences in survival after in-hospital cardiac arrest. JAMA (2009) 2.65

Predictors of adherence to performance measures in patients with acute myocardial infarction. Am J Med (2012) 2.64

Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol (2011) 2.63

Quality measurement in adult cardiac surgery: part 1--Conceptual framework and measure selection. Ann Thorac Surg (2007) 2.60

Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol (2005) 2.59

Quality measurement in adult cardiac surgery: part 2--Statistical considerations in composite measure scoring and provider rating. Ann Thorac Surg (2007) 2.59

Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA (2004) 2.55

Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J (2005) 2.55

Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol (2008) 2.55

Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation (2012) 2.54

Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation (2008) 2.53

Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program. Circulation (2010) 2.53

2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 2.52

Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial. Circulation (2011) 2.52

Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation (2006) 2.51